Ribas R, Pancholi S, Rani A, Schuster E, Guest S, Nikitorowicz Buniak J, et al. Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer. Breast Cancer Res. 2018;20:44 pubmed publisher

Färkkilä A, Andersson N, Butzow R, Leminen A, Heikinheimo M, Anttonen M, et al. HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up study. Cancer Med. 2014;3:526-36 pubmed publisher

Jay S, Kurtagic E, Alvarez L, de Picciotto S, Sanchez E, Hawkins J, et al. Engineered bivalent ligands to bias ErbB receptor-mediated signaling and phenotypes. J Biol Chem. 2011;286:27729-40 pubmed publisher

Okwueze M, Cardwell N, Pollins A, Nanney L. Modulation of porcine wound repair with a transfected ErbB3 gene and relevant EGF-like ligands. J Invest Dermatol. 2007;127:1030-41 pubmed

Hernes E, Fossa S, Berner A, Otnes B, Nesland J. Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. Br J Cancer. 2004;90:449-54 pubmed